Status:
UNKNOWN
Temperature Gradients for Sepsis Severity and Fluid Resuscitation
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
The assessment and treatment of Septic Shock (SS) is a thorny issue in current care. Fluid resuscitation is one of the key measures for SS treatment. Current fluid resuscitation is dominated by empiri...
Detailed Description
Sepsis remains a great challenge for clinicians. Early and timely fluid resuscitation is the basic measure for the treatment of sepsis. It is important to quickly diagnose the severity of sepsis and e...
Eligibility Criteria
Inclusion
- Older than 17 years old.
- Patients with sepsis or septic shock who meet the diagnostic criteria for sepsis 3.0 and who are routinely treated according to 《Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016》.
- Get informed consent within 2 hours.
Exclusion
- Age \<18 years old.
- A confirmed pregnancy or urine pregnancy test is positive.
- Patients with septic shock at low temperature (central body temperature \<35 °C).
- The informed consent of the legal representative of the subject was not obtained.
- Known liver disease affecting peripheral perfusion assessment, such as vascular occlusive vasculitis, multiple arteritis, and Raynaud's disease.
- Any disease that restricts the use of fluid resuscitation, such as: heart failure, major cardiac surgery, post-cardiopulmonary resuscitation, severe heart disease.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT04068298
Start Date
September 1 2019
End Date
September 1 2022
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NanFang hospital
Guangzhou, Guangdong, China, 510515